General Information of the Compound
| Compound ID |
CP0440078
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[4-[2-[[(2R)-2-hydroxy-2-pyridin-3-ylethyl]amino]ethyl]phenyl]-4-[5-[[4-(methanesulfonamido)phenyl]methyl]-1,2,4-oxadiazol-3-yl]benzenesulfonamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C31H32N6O6S2
|
||||||||||||||||||
| Molecular Weight |
648.767
|
||||||||||||||||||
| Canonical SMILES |
CS(=O)(=O)Nc1ccc(Cc2nc(no2)-c2ccc(cc2)S(=O)(=O)Nc2ccc(CCNC[C@H](O)c3cccnc3)cc2)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C31H32N6O6S2/c1-44(39,40)36-26-12-6-23(7-13-26)19-30-34-31(35-43-30)24-8-14-28(15-9-24)45(41,42)37-27-10-4-22(5-11-27)16-18-33-21-29(38)25-3-2-17-32-20-25/h2-15,17,20,29,33,36-38H,16,18-19,21H2,1H3/t29-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
JLGFGRUIACKCGA-LJAQVGFWSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01179, Beta-1 adrenergic receptor
Protein ID: PT01494, Beta-2 adrenergic receptor
Protein ID: PT01493, Beta-3 adrenergic receptor